Literature DB >> 16091259

Plastic surgical approaches for HIV-associated lipoatrophy.

Graeme J Moyle1.   

Abstract

Prolonged antiretroviral therapy, particularly with thymidine analogue-based regimens, may lead to generalized lipoatrophy. The facial changes associated with lipoatrophy are highly stigmatizing, affecting quality of life and decisions around therapy. Changes in antiretrovirals to thymindine-sparing regimens may lead to gradual fat recovery but, even over several years, may not result in impressive restoration of appearance. The need for a rapid and effective panacea for facial changes has led to investigation of a range of cosmetic treatments to enhance facial appearance. Surgical fillers, which may be either permanent or biodegradable, are the mainstay of cosmetic management. These treatments not only lead to improved physical appearance but also may reduce social anxiety and depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091259     DOI: 10.1007/s11904-005-0005-7

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  14 in total

1.  Local treatment of facial lipodystrophy in patients receiving HIV protease inhibitor therapy.

Authors:  M J Ritt; M E Hillebrand-Haverkort; J H ten Veen
Journal:  Acta Chir Plast       Date:  2001

2.  [Surgical treatment of facial lipoatrophy].

Authors:  N Caye; B Le Fourn; M Pannier
Journal:  Ann Chir Plast Esthet       Date:  2003-02       Impact factor: 0.660

3.  Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.

Authors:  H Hatano; K D Miller; C P Yoder; J A Yanovski; N G Sebring; E C Jones; R T Davey
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

4.  Facial atrophy in HIV-related fat redistribution syndrome: anatomic evaluation and surgical reconstruction.

Authors:  Mia Talmor; Lloyd A Hoffman; Gregory S LaTrenta
Journal:  Ann Plast Surg       Date:  2002-07       Impact factor: 1.539

5.  A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds.

Authors:  Rhoda S Narins; Fredric Brandt; James Leyden; Z Paul Lorenc; Mark Rubin; Stacy Smith
Journal:  Dermatol Surg       Date:  2003-06       Impact factor: 3.398

6.  A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone.

Authors:  David Orentreich; Anna-Sophia Leone
Journal:  Dermatol Surg       Date:  2004-04       Impact factor: 3.398

7.  Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

Authors:  Allison Martin; Don E Smith; Andrew Carr; Clare Ringland; Janaki Amin; Sean Emery; Jennifer Hoy; Cassy Workman; Nicholas Doong; Judith Freund; David A Cooper
Journal:  AIDS       Date:  2004-04-30       Impact factor: 4.177

8.  A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection.

Authors:  G J Moyle; L Lysakova; S Brown; N Sibtain; J Healy; C Priest; S Mandalia; S E Barton
Journal:  HIV Med       Date:  2004-03       Impact factor: 3.180

9.  Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

Authors:  Marc-Antoine Valantin; Camille Aubron-Olivier; Jade Ghosn; Elisabeth Laglenne; Michelle Pauchard; Hélène Schoen; Raymond Bousquet; Philippe Katz; Dominique Costagliola; Christine Katlama
Journal:  AIDS       Date:  2003-11-21       Impact factor: 4.177

10.  Bio-Alcamid in drug-induced lipodystrophy.

Authors:  Carmelo Protopapa; Giuseppe Sito; Domenico Caporale; Nazzareno Cammarota
Journal:  J Cosmet Laser Ther       Date:  2003-12       Impact factor: 2.247

View more
  2 in total

Review 1.  HIV protease inhibitors and obesity.

Authors:  Erdembileg Anuurad; Andrew Bremer; Lars Berglund
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-10       Impact factor: 3.243

Review 2.  Metabolic complications and treatment of perinatally HIV-infected children and adolescents.

Authors:  Linda Barlow-Mosha; Allison Ross Eckard; Grace A McComsey; Philippa M Musoke
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.